Clinical trial
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
NCT00375934 is registered in ClinicalTrials.gov with Xanodyne Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
- Lead sponsor
- Xanodyne Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- Not reported
- Enrollment
- 200 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative